MedTrace Logo

Digitally Delivered Dietary Treament for Adult Patients With Irritable Bowel Syndrome: A Pilot Study

NCT07607132 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-05-26

No results posted yet for this study

Summary

Two carbohydrate reduced diets, the low FODMAP diet (LFD) and low-carbohydrate diet (LCD), have in randomized controlled studies shown efficacy in relieving symptoms in patients with Irritable Bowel Syndrome (IBS), but access to dieticians is limited. Digital delivery may offer a convenient, cost-effective and scalable solution. This pilot study aim to evaluate the effectiveness and feasibility of digitally delivering evidence-based diets in relieving gastrointestinal, psychological and somatic symptoms and quality of life in patients with IBS.

Adults with IBS will be recruited via social media and clinical referrals and will receive their choice of the two dietary treatments: LFD with traditional IBS dietary advice or LCD. Participants will get access to a digital platform with information about the study, IBS, the treatment diet along with recipes and a mobile application for food scanning. Participants will complete digital questionnaires at baseline and week four to evaluate changes in gastrointestinal symptoms (IBS-SSS), somatic and psychological symptoms (PHQ-15, HADS, VSI) and quality of life (IBS-QoL). Feasibility and adherence is assessed with an evaluation questionnaire.

Conditions

  • Irritable Bowel Syndrome

Interventions

OTHER

Digital dietary platform

a digital platform with information about the study, IBS, the treatment diet along with recipes and a mobile application for food scanning.

Sponsors & Collaborators

  • Funding: Kostfonden

    collaborator UNKNOWN

  • Sahlgrenska University Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-02
Primary Completion
2025-04-01
Completion
2025-04-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07607132 on ClinicalTrials.gov